10 03, 2020

Supporting Our Patients and Research Subjects Amidst COVID-19 Concerns

2020-04-15T19:17:29+00:00March 10th, 2020|

By now, you have likely heard about the Coronavirus (officially called “2019-Novel Coronavirus” or “COVID-19”) in the news. While the immediate health risk remains low to Americans, there are still ways that all of us can play a role in helping to prevent the spread of this and other viruses. With that said, Clinilabs, the [...]

20 02, 2020

Clinilabs Drug Development Corporation Achieves CNS Trial Start-Up in 1/3 the Time of Industry Standard

2020-02-27T16:24:07+00:00February 20th, 2020|

Clinilabs Drug Development Corporation, the only global, full-service contract research organization (CRO) focused exclusively on central nervous system (CNS) drug development, was engaged by a large, clinical-stage biopharmaceutical company to manage a randomized, double-blind, placebo-controlled study of a therapy for patients with acute migraine headache. The pivotal trial, involving 100 sites, various demographics and [...]

22 01, 2020

Clinilabs Reduces Patient Outreach Time by 85%

2020-01-27T23:53:08+00:00January 22nd, 2020|

Clinilabs Drug Development Corporation, a mid-sized, full-service CRO that provides a full range of clinical drug development services, has been utilizing Facebook advertising as an essential tool for generating study participant leads with good success. In fact, Facebook recruitment has been one of Clinilabs’ fastest responding and lowest cost recruitment tools. But even with the [...]

17 10, 2019

Clinilabs Drug Development Corporation and SureClinical Announce Global Lunch & Learn Series for Clinical Operations

2020-01-22T18:13:49+00:00October 17th, 2019|

Clinilabs Drug Development Corporation, a CNS-focused contract research organization, and SureClinical, a global provider of innovative cloud solutions for the health sciences market, are sponsoring a global Lunch & Learn series demonstrating how sponsors can streamline and accelerate the clinical trials process. Focusing on real-world examples, Clinilabs will reveal strategies that cut their site initiation [...]

10 09, 2018

SureClinical Announces SureCTMS, First Mobile eClinical Trial Management System

2018-09-20T17:05:07+00:00September 10th, 2018|

SureClinical has announced the release and FDA compliance validation of SureCTMS, its cloud-based clinical trial management application.  As part of SureClinical’s best-in-class platform and suite of eClinical applications, SureCTMS helps teams manage projects more effectively, accelerate project completion milestones, enhance quality, and lower costs.  This has helped CROs manage trials more efficiently.  “Our users, sponsors, and [...]

6 07, 2018

Assure Screen

2018-07-26T22:35:05+00:00July 6th, 2018|

Clinilabs Drug Development Corporation and Verified Clinical Trials (VCT) are pleased to announce the launch of Assure Screen, a pre-screening program for clinical trial participants that helps to reduce screen failure rates and the costs associated with screening study candidates.  The Assure Screen program enables investigators to obtain informed consent from subjects to participate [...]

25 03, 2018

ASCPT 2018: ‘Six Keys to Running Successful Phase 1 Studies’

2018-04-26T19:47:41+00:00March 25th, 2018|

Clinilabs Drug Development Corporation sponsored an educational event at this year's meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT), which was held in Orlando, FL March 21 - 24.  The event, "Six Keys to Running Successful Phase 1 Studies," provided deep insights into the objectives, strategies, and tactics common to the efficient [...]

18 12, 2017

Expansion of Regional Offices

2019-10-17T21:03:44+00:00December 18th, 2017|

Clinilabs Drug Development Corporation is pleased to announce that it has established two new regional offices in 2017. An office has been established in San Diego, California in order to accommodate the increasing number of West Coast sponsors now working with the company. The office provides a convenient location for its regional staff, and enables [...]

17 12, 2017

Epilepsy Monitoring Unit

2019-10-16T14:30:28+00:00December 17th, 2017|

Clinilabs Drug Development Corporation is pleased to announce that it has established a 6-bed epilepsy monitoring unit at its New York City facility. The facility, which boasts a 50-bed inpatient capacity for clinical studies, offers sponsors and subjects six comfortable, private rooms for video EEG monitoring. Each room is equipped with premium bedding, with beds [...]